Source:
NY TimesMonths after McNeil Consumer Healthcare, a unit of Johnson & Johnson, recalled millions of bottles of Tylenol and other over-the-counter drugs, the division is still plagued with manufacturing flaws, according to the Food and Drug Administration.
Agency officials who filed an inspection report, posted on the agency’s Web site this month, about a McNeil plant in Puerto Rico cited a variety of problems: distribution of drugs that failed quality requirements, a failure to identify product defects during routine testing, failure to detect incorrect expiration dates on drug labels, failure to adequately investigate product problems, failure to follow laboratory controls and inadequate training of lab staff.
Last January, the agency sent a warning letter to Peter Luther, the president of McNeil, about significant manufacturing violations at the same plant. The new inspection report indicates that some problems have not been corrected, said Karen Riley, a spokeswoman for the F.D.A.
“Clearly, this inspection shows that the company continues to have serious quality control issues at its plant and that it is not in compliance with current good manufacturing practices required by federal law,” Ms. Riley said Friday. The agency, she added, was not aware of any harm to consumers associated with the latest problems at that plant.
Read more:
http://www.nytimes.com/2010/11/27/business/27drug.html?_r=1&hp